BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21255808)

  • 1. Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.
    Wang HW; Mizuta M; Saitoh Y; Noma K; Ueno H; Nakazato M
    Metabolism; 2011 Aug; 60(8):1081-9. PubMed ID: 21255808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
    Saitoh Y; Hongwei W; Ueno H; Mizuta M; Nakazato M
    Diabetes Res Clin Pract; 2010 Oct; 90(1):54-9. PubMed ID: 20667613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
    Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of glucagon-like peptide-1 on the free fatty acid-induced expression of pancreatic derived factor in cultured β-TC3 cell line].
    Chen S; Cao XP; Xiao HP; Li YB
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1413-6. PubMed ID: 21756815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
    Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
    J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
    Wei Q; Sun YQ; Zhang J
    Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
    Fan R; Li X; Gu X; Chan JC; Xu G
    Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
    Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin attenuates palmitate-induced apoptosis in MIN6 pancreatic β-cells through PI3K/Akt/FoxO1 and mitochondrial survival pathways.
    Hao F; Kang J; Cao Y; Fan S; Yang H; An Y; Pan Y; Tie L; Li X
    Apoptosis; 2015 Nov; 20(11):1420-32. PubMed ID: 26330141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic beta-cells.
    Wang W; Liu Y; Chen Y; Cao C; Xiang Y; Zhang D; Han L; Zhao H; Liu G
    Peptides; 2010 Feb; 31(2):307-14. PubMed ID: 19944124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
    J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.
    Klinger S; Poussin C; Debril MB; Dolci W; Halban PA; Thorens B
    Diabetes; 2008 Mar; 57(3):584-93. PubMed ID: 18025410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.
    Shao JQ; Iwashita N; Du H; Wang YT; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Acta Pharmacol Sin; 2007 Feb; 28(2):246-57. PubMed ID: 17241528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
    Tews D; Werner U; Eckel J
    Horm Metab Res; 2008 Mar; 40(3):172-80. PubMed ID: 18348079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes outfoxed by GLP-1?
    Holz GG; Chepurny OG
    Sci STKE; 2005 Jan; 2005(268):pe2. PubMed ID: 15671479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
    Uhles S; Wang H; Bénardeau A; Prummer M; Brecheisen M; Sewing S; Tobalina L; Bosco D; Wollheim CB; Migliorini C; Sebokova E
    Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis.
    Liu J; Yin F; Xiao H; Guo L; Gao X
    Toxicol In Vitro; 2012 Oct; 26(7):1093-7. PubMed ID: 22819839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1.
    Green BD; Liu HK; McCluskey JT; Duffy NA; O'Harte FP; McClenaghan NH; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):563-9. PubMed ID: 16050949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.